EUVIMEDEUVIMED entdecken
Crossref

Classifying cancer-associated fibroblasts—The good, the bad, and the target

Lena Cords, Natalie de Souza, Bernd Bodenmiller

Cancer Cell · 2024-09 · 42 (9) · 1480-1485

DOI: 10.1016/j.ccell.2024.08.011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Cell, 2024-09. Verfasst von Lena Cords und 2 weiteren Autor:innen. Beteiligte Einrichtung: University of Zurich, Department of Quantitative Biomedicine, Zurich, Switzerland; ETH Zurich, Institute of Molecular Health Sciences, Zurich, Switze…. Hauptthemen laut MEDLINE: Cancer-Associated Fibroblasts, Tumor Microenvironment, Neoplasms, Single-Cell Analysis. Die Arbeit wurde bisher 142-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: European Research Council, Horizon 2020 Framework Programme, NIH Library.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer-associated fibroblasts (CAFs) are heterogeneous and ubiquitous stromal cells within the tumor microenvironment (TME). Numerous CAF types have been described, typically using single-cell technologies such as single-cell RNA sequencing. There is no general classification system for CAFs, hampering their study and therapeutic targeting. We propose a simple CAF classification system based on single-cell phenotypes and spatial locations of CAFs in multiple cancer types, assess how our scheme fits within current knowledge, and invite the CAF research community to further refine it.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cancer-Associated FibroblastsTumor MicroenvironmentNeoplasmsSingle-Cell AnalysisHumansPhenotypeAnimals

Autor:innen und Institutionen

  • University of Zurich, Department of Quantitative Biomedicine, Zurich, Switzerland; ETH Zurich, Institute of Molecular Health Sciences, Zurich, Switzerland.
  • University of Zurich, Department of Quantitative Biomedicine, Zurich, Switzerland; ETH Zurich, Institute of Molecular Health Sciences, Zurich, Switzerland; ETH Zurich, Institute of Molecular Systems Biology, Zurich, Swi…
  • University of Zurich, Department of Quantitative Biomedicine, Zurich, Switzerland; ETH Zurich, Institute of Molecular Health Sciences, Zurich, Switzerland. Electronic address: bernd.bodenmiller@uzh.ch.

Förderung

  • European Research Council
  • Horizon 2020 Framework Programme
  • NIH Library
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
  • European Commission
  • Cancer Research UK

Zitieren

APA

Cords, L., de Souza, N., & Bodenmiller, B. (2024). Classifying cancer-associated fibroblasts—The good, the bad, and the target. Cancer Cell, 42(9), 1480-1485. https://doi.org/10.1016/j.ccell.2024.08.011

Vancouver

Cords L, de Souza N, Bodenmiller B. Classifying cancer-associated fibroblasts—The good, the bad, and the target. Cancer Cell. 2024;42(9):1480-1485. doi:10.1016/j.ccell.2024.08.011

BibTeX
@article{Cords2024,
  author = {Cords, Lena and de Souza, Natalie and Bodenmiller, Bernd},
  title = {Classifying cancer-associated fibroblasts—The good, the bad, and the target},
  journal = {Cancer Cell},
  year = {2024},
  volume = {42},
  number = {9},
  pages = {1480--1485},
  doi = {10.1016/j.ccell.2024.08.011}
}
Kostenlos starten →